One of the latest voices weighing in is Jason Gerberry of Bank of America, who reiterated a Hold (Neutral) stance on Pfizer on February 4, 2026, setting a price objective of $27.00. This target sits ...

Overview: Pfizer stock is trading near $25.86 with moderate upside potential based on the forecast range of up to ...

“Pfizer appears cheap with a near 7% yield, but capital allocation constraints undermine its investment case. Nearly all of ...

TipRanks Ranking Metrics: This 4-star analyst ranks #324 out of 11,984, with a 61.73% success rate and a 15.50% average return per rating. Investors tracking Gerberry’s calls may appreciate his ...

Is Pfizer stock a buy at under 9x earnings? Yes. It is.

Analysts expect Pfizer’s revenue to decrease approximately 5% to around $16.95 billion, while adjusted earnings per share are projected to fall 9.5% to 57 cents compared to 63 cents in the same period ...

Analysts expect the New York-based company to report quarterly earnings at 57 cents per share, down from 63 cents per share ...

Pfizer Inc. (PFE) shares are trading higher on Tuesday, as the stock benefits from a price target increase at Cantor ...

Pfizer posted adjusted earnings of 66 cents per share, beating the 57 cents forecast by analysts, News.Az reports, citing foreign ...

PayPal ( PYPL) stock tumbled 16.9% before the opening bell after the fintech issued disappointing guidance, delivered weaker-than-expected Q4 earnings and revenue, and replaced its CEO. The board ...